![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
Affymax, Takeda launch OMONTYS injection in US
Affymax and Takeda Pharmaceutical Company have announced the availability of OMONTYS injection to treat...
Watson introduces generic version of Fortamet
Watson Pharmaceuticals has introduced an authorized generic version of Fortamet as a part of...
Elis Pharma to present erectile dysfunction drug Vitaros at Dubai event
Elis Pharmaceuticals will present erectile dysfunction drug Vitaros licensed from Apricus Biosciences at the...
EyeScience develops new eye vitamin for diabetes patients
EyeScience Labs, a resource in ocular nutrition and maker of EyeScience Macular Health Formula...
APP Pharmaceuticals receives marketing approval for Methotrexate Injection
APP Pharmaceuticals, a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals, has received FDA approval...
Ranbaxy launches cholesterol reducing drug in Australia
Ranbaxy Australia, a subsidiary of Ranbaxy Laboratories, has introduced Atorvastatin 10mg, 20mg, 40mg and...
La Jolla buys GCS-100 rights from Solana
La Jolla Pharmaceutical Company has acquired global development and commercialization rights to GCS-100 from...
Novartis receives Morrison & Foerster advice on Camurus deal
The global law firm, Morrison & Foerster has advised Novartis to sign an exclusive...
Mymetics regains intra-nasal influenza vaccine from Solvay
Mymetics, a developer of next-generation preventative vaccines, has regained its intra-nasal influenza vaccine from Solvay.Mymetics...
The Medicines Company introduces new Cleviprex formulation
The Medicines Company has launched a new twelve hour formulation for the FDA approved Cleviprex...